![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0780.jpg)
The first study of dabrafenib in pediatric
patients with BRAF V600-mutant relapsed
or refractory low-grade gliomas
Mark Kieran, Eric Bouffet, Uri Tabori, Alberto Broniscer, Kenneth Cohen,
Jordan R. Hansford, Birgit Geoerger, Pooja Hingorani, Ira Dunkel, Mark Russo,
Lillian Tseng, Qing Liu, Noelia Nebot, Jim Whitlock, Darren Hargrave